Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

How our clients use DrugPatentWatch

Generated: April 26, 2017

DrugPatentWatch Database Preview

Nitrofurantoin, macrocrystalline - Generic Drug Details

« Back to Dashboard

What are the generic drug sources for nitrofurantoin, macrocrystalline and what is the scope of patent protection?

Nitrofurantoin, macrocrystalline
is the generic ingredient in three branded drugs marketed by Alvogen Malta, Sun Pharm Inds, Mylan, Sandoz, Watson Labs, Impax Labs Inc, and Actavis Labs Fl Inc, and is included in eleven NDAs. There is one patent protecting this compound. Additional information is available in the individual branded drug profile pages.

Thirty-two suppliers are listed for this compound.

Summary for Generic Name: nitrofurantoin, macrocrystalline

Tradenames:3
Patents:1
Applicants:7
NDAs:11
Suppliers / Packagers: see list32
Bulk Api Vendors: see list48
Clinical Trials: see list6
Patent Applications: see list6,331
Formulation / Manufacturing:see details
Drug Prices:see low prices
DailyMed Link:nitrofurantoin, macrocrystalline at DailyMed

Pharmacology for Ingredient: nitrofurantoin, macrocrystalline

Ingredient-typeNitrofurans
Drug ClassNitrofuran Antibacterial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Watson Labs
NITROFURANTOIN
nitrofurantoin, macrocrystalline
CAPSULE;ORAL073696-003Dec 31, 1992DISCNNoNo► Subscribe► Subscribe
Actavis Labs Fl Inc
NITROFURANTOIN
nitrofurantoin, macrocrystalline
CAPSULE;ORAL091095-002Jun 18, 2015ABRXNoNo► Subscribe► Subscribe
Impax Labs Inc
NITROFURANTOIN
nitrofurantoin, macrocrystalline
CAPSULE;ORAL073652-001Jan 28, 1993ABRXNoNo► Subscribe► Subscribe
Sun Pharm Inds
NITROFURANTOIN
nitrofurantoin, macrocrystalline
CAPSULE;ORAL201722-002Feb 16, 2016ABRXNoNo► Subscribe► Subscribe
Sun Pharm Inds
NITROFURANTOIN
nitrofurantoin, macrocrystalline
CAPSULE;ORAL201722-001Feb 16, 2016ABRXNoNo► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Subscribe for Complete Access

  • Analyze global market entry opportunities
  • Formulary management
  • Set up watchlists for daily email updates

► Plans and Pricing

Expired Orange Book Patents

 Available with subscription

Paragraph IV Activity

 Available with subscription

Patent Maintenance

 Available with subscription

Non-Orange Book Patents

 Available with subscription

International Patents

 Available with subscription

Supplementary Protection Certificates

 Available with subscription

« Back to the Dashboard

For more information try a trial or see the database preview and plans and pricing

How our clients use DrugPatentWatch

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot